Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Brachmann

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Cancer Research|March 17, 2006
Overexpression of the oncoprotein prothymosin alpha triggers a p53 response that involves p53 acetylationTakahiko Kobayashi, Ting Wang, Masaji Maezawa, et al.
Breast Cancer Research and Treatment|August 18, 2020
Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancerJennifer R Diamond, Carlos Becerra, Donald Richards, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics|October 20, 2006
Functional census of mutation sequence spaces: the example of p53 cancer rescue mutantsSamuel A Danziger, S Joshua Swamidass, Jue Zeng, et al.
Molecular Ecology Resources|May 29, 2023
Genomic and machine learning-based screening of aquaculture-associated introgression into at-risk wild North American Atlantic salmon (Salmo salar) populationsCameron M Nugent, Tony Kess, Matthew K Brachmann, et al.
Molecular Ecology Resources|December 3, 2021
Reference genome of lumpfish Cyclopterus lumpus Linnaeus provides evidence of male heterogametic sex determination through the AMH pathwayMelissa K Holborn, Anthony L Einfeldt, Tony Kess, et al.
International Journal of Cancer|March 24, 2010
p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5Takahiko Kobayashi, Junich Ishida, Manabu Musashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2020
Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic CancerEfrat Dotan, Dana B Cardin, Heinz-Josef Lenz, et al.
Plos One|April 6, 2019
Design and characterization of an 87k SNP genotyping array for Arctic charr (Salvelinus alpinus)Cameron M Nugent, Jong S Leong, Kris A Christensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2012
Phosphoinositide 3-kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical modelsJill M Spoerke, Carol O'Brien, Ling Huw, et al.
Cancer Chemotherapy and Pharmacology|March 18, 2014
A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumorsAmita Patnaik, Patricia M LoRusso, Wells A Messersmith, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Cancer Research|March 17, 2006
Overexpression of the oncoprotein prothymosin alpha triggers a p53 response that involves p53 acetylationTakahiko Kobayashi, Ting Wang, Masaji Maezawa, et al.
Breast Cancer Research and Treatment|August 18, 2020
Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancerJennifer R Diamond, Carlos Becerra, Donald Richards, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics|October 20, 2006
Functional census of mutation sequence spaces: the example of p53 cancer rescue mutantsSamuel A Danziger, S Joshua Swamidass, Jue Zeng, et al.
Molecular Ecology Resources|May 29, 2023
Genomic and machine learning-based screening of aquaculture-associated introgression into at-risk wild North American Atlantic salmon (Salmo salar) populationsCameron M Nugent, Tony Kess, Matthew K Brachmann, et al.
Molecular Ecology Resources|December 3, 2021
Reference genome of lumpfish Cyclopterus lumpus Linnaeus provides evidence of male heterogametic sex determination through the AMH pathwayMelissa K Holborn, Anthony L Einfeldt, Tony Kess, et al.
International Journal of Cancer|March 24, 2010
p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5Takahiko Kobayashi, Junich Ishida, Manabu Musashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2020
Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic CancerEfrat Dotan, Dana B Cardin, Heinz-Josef Lenz, et al.
Plos One|April 6, 2019
Design and characterization of an 87k SNP genotyping array for Arctic charr (Salvelinus alpinus)Cameron M Nugent, Jong S Leong, Kris A Christensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2012
Phosphoinositide 3-kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical modelsJill M Spoerke, Carol O'Brien, Ling Huw, et al.
Cancer Chemotherapy and Pharmacology|March 18, 2014
A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumorsAmita Patnaik, Patricia M LoRusso, Wells A Messersmith, et al.
Pageof 5